Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates

Authors: Alessandra Estrela-Lima, Márcio SS Araújo, João M Costa-Neto, Andréa Teixeira-Carvalho, Stella M Barrouin-Melo, Sergio V Cardoso, Olindo A Martins-Filho, Rogéria Serakides, Geovanni D Cassali

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

The immune system plays an important role in the multifactorial biologic system during the development of neoplasias. However, the involvement of the inflammatory response in the promotion/control of malignant cells is still controversial, and the cell subsets and the mechanisms involved are poorly investigated. The goal of this study was to characterize the clinical-pathological status and the immunophenotyping profile of tumor infiltrating lymphocytes and their association with the animal survival rates in canine mammary carcinomas.

Methods

Fifty-one animals with mammary carcinomas, classified as carcinomas in mixed tumors-MC-BMT = 31 and carcinomas-MC = 20 were submitted to systematic clinical-pathological analysis (tumor size; presence of lymph node and pulmonary metastasis; clinical stage; histological grade; inflammatory distribution and intensity as well as the lymphocytic infiltrate intensity) and survival rates. Twenty-four animals (MC-BMT = 16 and MC = 8) were elected to the immunophenotypic study performed by flow cytometry.

Results

Data analysis demonstrated that clinical stage II-IV and histological grade was I more frequent in MC-BMT as compared to MC. Univariate analysis demonstrated that the intensity of inflammation (moderate/intense) and the proportion of CD4+ (≥ 66.7%) or CD8+ T-cells (<33.3%) were not associated with worse survival rate. Multivariate analysis demonstrated that only lymphocytic infiltrate intensity ≥ 600 (P = 0.02) remained as independent prognostic factor. Despite the clinical manifestation, the lymphocytes represented the predominant cell type in the tumor infiltrate. The percentage of T-cells was higher in animals with MC-BMT without metastasis, while the percentage of B-lymphocytes was greater in animals with metastasized MC-BMT (P < 0.05). The relative percentage of CD4+ T-cells was significantly greater in metastasized tumors (both MC-BMT and MC), (P < 0.05) while the proportion of CD8+ T-cells was higher in MC-BMT without metastasis. Consequently, the CD4+/CD8+ ratio was significantly increased in both groups with metastasis. Regardless of the tumor type, the animals with high proportions of CD4+ and low CD8+ T-cells had decreased survival rates.

Conclusion

The intensity of lymphocytic infiltrate and probably the relative abundance of the CD4+ and CD8+ T-lymphocytes may represent important survival prognostic biomarkers for canine mammary carcinomas.
Appendix
Available only for authorised users
Literature
1.
go back to reference Misdorp W: Tumors of the mammary gland. Tumors in Domestic Animals. Edited by: Meuten DJ. 2002, Iowa State: University of California, 575-606. full_text. 4 Misdorp W: Tumors of the mammary gland. Tumors in Domestic Animals. Edited by: Meuten DJ. 2002, Iowa State: University of California, 575-606. full_text. 4
2.
go back to reference Peleteiro MC: Tumores mamários na cadela e na gata. Revista Portuguesa de Ciências Veterinárias. 1994, 89 (509): 10-29. Peleteiro MC: Tumores mamários na cadela e na gata. Revista Portuguesa de Ciências Veterinárias. 1994, 89 (509): 10-29.
3.
go back to reference Cassali GD, Gobbi H, Malm C, Schmitt FC: Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours. Cytopathology. 2007, 18 (3): 191-6.PubMed Cassali GD, Gobbi H, Malm C, Schmitt FC: Evaluation of accuracy of fine needle aspiration cytology for diagnosis of canine mammary tumours: comparative features with human tumours. Cytopathology. 2007, 18 (3): 191-6.PubMed
4.
go back to reference Genelhu MC, Cardoso SV, Gobbi H, Cassali GD: A comparative study between mixed-type tumors from human salivary and canine mammary glands. BMC Cancer. 2007, 7: 218-10.1186/1471-2407-7-218.CrossRefPubMedPubMedCentral Genelhu MC, Cardoso SV, Gobbi H, Cassali GD: A comparative study between mixed-type tumors from human salivary and canine mammary glands. BMC Cancer. 2007, 7: 218-10.1186/1471-2407-7-218.CrossRefPubMedPubMedCentral
5.
go back to reference Bertagnolli AC, Cassali GD, Genelhu MCLS, Costa FA, Oliveira JFC, Gonçalves PBD: Immunohistochemical expression of p63 and {Delta}Np63 in mixed tumors of canine mammary glands and its relation with p53 expression. Veterinary Pathology. 2009, 46: 407-415. 10.1354/vp.08-VP-0128-C-FL.CrossRefPubMed Bertagnolli AC, Cassali GD, Genelhu MCLS, Costa FA, Oliveira JFC, Gonçalves PBD: Immunohistochemical expression of p63 and {Delta}Np63 in mixed tumors of canine mammary glands and its relation with p53 expression. Veterinary Pathology. 2009, 46: 407-415. 10.1354/vp.08-VP-0128-C-FL.CrossRefPubMed
6.
go back to reference Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, Marconato L, Abramo F, Ciliberto G, Lahm A, Monica N, Rinaldis E: Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics. 2009, 135 (10): 1-20. Uva P, Aurisicchio L, Watters J, Loboda A, Kulkarni A, Castle J, Palombo F, Viti V, Mesiti G, Zappulli V, Marconato L, Abramo F, Ciliberto G, Lahm A, Monica N, Rinaldis E: Comparative expression pathway analysis of human and canine mammary tumors. BMC Genomics. 2009, 135 (10): 1-20.
7.
go back to reference Denardo DG, Coussens LM: Review Inflammation and breast cancer: Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Research. 2007, 9 (4): s10-10.1186/bcr1746.CrossRef Denardo DG, Coussens LM: Review Inflammation and breast cancer: Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression. Breast Cancer Research. 2007, 9 (4): s10-10.1186/bcr1746.CrossRef
8.
go back to reference Coussens LM, Werb Z: Inflammatory cells and cancer: think different!. Journal Experimental Medicine. 2001, 193 (6): 23-26. 10.1084/jem.193.6.F23.CrossRef Coussens LM, Werb Z: Inflammatory cells and cancer: think different!. Journal Experimental Medicine. 2001, 193 (6): 23-26. 10.1084/jem.193.6.F23.CrossRef
9.
go back to reference De Visser KE, Eichten A, Coussen L: Paradoxical roles of the immune during cancer development. Nature Reviews. 2006, 6: 24-40. 10.1038/nrc1782.PubMed De Visser KE, Eichten A, Coussen L: Paradoxical roles of the immune during cancer development. Nature Reviews. 2006, 6: 24-40. 10.1038/nrc1782.PubMed
10.
go back to reference Stewart THM, Heppner GH: Immunological enhancement of breast cancer. Parasitology. 1997, 115: 141-153. 10.1017/S0031182097001832.CrossRef Stewart THM, Heppner GH: Immunological enhancement of breast cancer. Parasitology. 1997, 115: 141-153. 10.1017/S0031182097001832.CrossRef
12.
go back to reference Thun MJ, Henley SJ, Gansler T: Inflammation and cancer: an epidemiological perspective. Novartis Found Symposium. 2004, 256: 6-21. full_text.CrossRef Thun MJ, Henley SJ, Gansler T: Inflammation and cancer: an epidemiological perspective. Novartis Found Symposium. 2004, 256: 6-21. full_text.CrossRef
13.
go back to reference Whiteside TL: The local tumor microenvironment. General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. Edited by: Kaufmann H, Wolchok JD. 2007, Springer, 145-167. full_text.CrossRef Whiteside TL: The local tumor microenvironment. General Principles of Tumor Immunotherapy: Basic and Clinical Applications of Tumor Immunology. Edited by: Kaufmann H, Wolchok JD. 2007, Springer, 145-167. full_text.CrossRef
14.
go back to reference Marx J: Inflammation and cancer: The link grows stronger. Science. 2004, 306: 966-968. 10.1126/science.306.5698.966.CrossRefPubMed Marx J: Inflammation and cancer: The link grows stronger. Science. 2004, 306: 966-968. 10.1126/science.306.5698.966.CrossRefPubMed
15.
go back to reference Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature. 2008, 454 (7203): 436-44. 10.1038/nature07205.CrossRefPubMed Mantovani A, Allavena P, Sica A, Balkwill F: Cancer-related inflammation. Nature. 2008, 454 (7203): 436-44. 10.1038/nature07205.CrossRefPubMed
16.
go back to reference Murri AM AI, Hilmy M, Bell J, Wilson C, McNicol AM, Lannigan A, Doughty JC, McMillan DC: The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. British Journal Cancer. 2008, 99: 1013-19. 10.1038/sj.bjc.6604667.CrossRef Murri AM AI, Hilmy M, Bell J, Wilson C, McNicol AM, Lannigan A, Doughty JC, McMillan DC: The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer. British Journal Cancer. 2008, 99: 1013-19. 10.1038/sj.bjc.6604667.CrossRef
17.
go back to reference Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjanen K: Lymphocytes infiltrates as a prognostic variable in female breast cancer. European Journal Cancer. 1992, 28: 859-864. 10.1016/0959-8049(92)90134-N.CrossRef Aaltomaa S, Lipponen P, Eskelinen M, Kosma VM, Marin S, Alhava E, Syrjanen K: Lymphocytes infiltrates as a prognostic variable in female breast cancer. European Journal Cancer. 1992, 28: 859-864. 10.1016/0959-8049(92)90134-N.CrossRef
18.
go back to reference Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Barth RJ: In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Annals Surgical Oncology. 1996, 3 (2): 176-184. 10.1007/BF02305798.CrossRef Camp BJ, Dyhrman ST, Memoli VA, Mott LA, Barth RJ: In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Annals Surgical Oncology. 1996, 3 (2): 176-184. 10.1007/BF02305798.CrossRef
19.
go back to reference Ben-Baruch A: Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Research. 2003, 31 (5): 31-36. Ben-Baruch A: Host microenvironment in breast cancer development: Inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Research. 2003, 31 (5): 31-36.
20.
go back to reference Rutten VP, Misdorp W, Gauthier A, Estrada M, Mialot JP, Parodi AL, Rutteman GR, Weyer K: Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature. Veterinary Immunopathology. 1990, 26 (3): 211-25. 10.1016/0165-2427(90)90092-7.CrossRef Rutten VP, Misdorp W, Gauthier A, Estrada M, Mialot JP, Parodi AL, Rutteman GR, Weyer K: Immunological aspects of mammary tumors in dogs and cats: a survey including own studies and pertinent literature. Veterinary Immunopathology. 1990, 26 (3): 211-25. 10.1016/0165-2427(90)90092-7.CrossRef
21.
go back to reference O'Sullivan C, Lewis CE: Tumour associated leucocytes: friends or foes in breast carcinoma. Journal Pathology. 1994, 172: 229-235. 10.1002/path.1711720302.CrossRef O'Sullivan C, Lewis CE: Tumour associated leucocytes: friends or foes in breast carcinoma. Journal Pathology. 1994, 172: 229-235. 10.1002/path.1711720302.CrossRef
22.
go back to reference Whiteside TL, Miescher S, Hurlimann J, Moretta L, von Fliedner : Clonal analysis and in situ characterization of lymphocytes infiltration human breast carcinomas. Cancer Immunology Immunotherapy. 1986, 23: 169-178. 10.1007/BF00205646.CrossRefPubMed Whiteside TL, Miescher S, Hurlimann J, Moretta L, von Fliedner : Clonal analysis and in situ characterization of lymphocytes infiltration human breast carcinomas. Cancer Immunology Immunotherapy. 1986, 23: 169-178. 10.1007/BF00205646.CrossRefPubMed
23.
go back to reference Nowak M, Madej JP, Rossowska J, Madej JA: Involvement of CD8+ cells in protective mechanisms in canine mammary adenocarcinomas (short communication). Bull Veterinary Institute Pulawy. 2007, 51: 445-448. Nowak M, Madej JP, Rossowska J, Madej JA: Involvement of CD8+ cells in protective mechanisms in canine mammary adenocarcinomas (short communication). Bull Veterinary Institute Pulawy. 2007, 51: 445-448.
24.
go back to reference Misdorp W, Else W, Hellm'en E, Lipscomb TP: Histological classification of the mammary tumors of the dog and the cat. Second Series. WHO International Histological Classification Tumors of Domestic Animals. 1999, Washington, DC, AFIP, 2: s59- Misdorp W, Else W, Hellm'en E, Lipscomb TP: Histological classification of the mammary tumors of the dog and the cat. Second Series. WHO International Histological Classification Tumors of Domestic Animals. 1999, Washington, DC, AFIP, 2: s59-
25.
go back to reference Cassali GD, Serakides R, Gärtner F, Schmitt FC: Invasive micropapillary carcinoma. A case report. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 2002, 54 (4): 366-369. 10.1590/S0102-09352002000400006.CrossRef Cassali GD, Serakides R, Gärtner F, Schmitt FC: Invasive micropapillary carcinoma. A case report. Arquivo Brasileiro de Medicina Veterinária e Zootecnia. 2002, 54 (4): 366-369. 10.1590/S0102-09352002000400006.CrossRef
26.
go back to reference Owen LN: TNM Classification of tumors in Domestic Animals. 1980, World Health Organization, Geneva, 26-32. Owen LN: TNM Classification of tumors in Domestic Animals. 1980, World Health Organization, Geneva, 26-32.
27.
go back to reference Luna LG: Manual of histologic staining methods of the Armed Forces Institute of Pathology. 1968, New York: McGraw Hill Luna LG: Manual of histologic staining methods of the Armed Forces Institute of Pathology. 1968, New York: McGraw Hill
28.
go back to reference Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: experience from a large study with long-term followup. Histopathology. 1991, 19: 403-410. 10.1111/j.1365-2559.1991.tb00229.x.CrossRefPubMed Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: experience from a large study with long-term followup. Histopathology. 1991, 19: 403-410. 10.1111/j.1365-2559.1991.tb00229.x.CrossRefPubMed
29.
go back to reference Van Diest JP, Baak JPA, Matze-Cok P, Wisse-Brekelmans EC, Van Galen CM, Kurver PH, Bellot SM, Fijnheer J, Van Gorp LH, Kwee WS: Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. Human Pathology. 1992, 23: 603-607. 10.1016/0046-8177(92)90313-R.CrossRefPubMed Van Diest JP, Baak JPA, Matze-Cok P, Wisse-Brekelmans EC, Van Galen CM, Kurver PH, Bellot SM, Fijnheer J, Van Gorp LH, Kwee WS: Reproducibility of mitosis counting in 2469 breast cancer specimens: Results from the multicenter morphometric mammary carcinoma project. Human Pathology. 1992, 23: 603-607. 10.1016/0046-8177(92)90313-R.CrossRefPubMed
30.
go back to reference Dutra AP, Azevedo Junior GM, Schmitt FC, Cassali GD: Assessment of cell proliferation and prognostic factors in canine mammary gland tumors. Arquivo Brasileiro Medicina Veterinaria e Zootecnia. 2008, 60 (6): 1403-1412.CrossRef Dutra AP, Azevedo Junior GM, Schmitt FC, Cassali GD: Assessment of cell proliferation and prognostic factors in canine mammary gland tumors. Arquivo Brasileiro Medicina Veterinaria e Zootecnia. 2008, 60 (6): 1403-1412.CrossRef
31.
go back to reference Lendrum AC: The staining of eosinophil polymorphs and enterochromaffin cells in histological sections. The Journal of Pathology and Bacteriology. 1944, 56 (3): 441-10.1002/path.1700560319.CrossRef Lendrum AC: The staining of eosinophil polymorphs and enterochromaffin cells in histological sections. The Journal of Pathology and Bacteriology. 1944, 56 (3): 441-10.1002/path.1700560319.CrossRef
32.
go back to reference Teixeira-Carvalho A, Martins-Filho OA, Andrade ZA, Cunha-Mello JR, Wilson RA, Correa-Oliveira R: The study of T-cell activation in peripheral blood and spleen of hepatosplenic patients suggests an exchange of cells between these two compartments in advanced human Schitosomiasis mansoni infection. Scandinavian Journal Immunology. 2002, 56: 315-322. 10.1046/j.1365-3083.2002.01133.x.CrossRef Teixeira-Carvalho A, Martins-Filho OA, Andrade ZA, Cunha-Mello JR, Wilson RA, Correa-Oliveira R: The study of T-cell activation in peripheral blood and spleen of hepatosplenic patients suggests an exchange of cells between these two compartments in advanced human Schitosomiasis mansoni infection. Scandinavian Journal Immunology. 2002, 56: 315-322. 10.1046/j.1365-3083.2002.01133.x.CrossRef
33.
go back to reference Araujo MSS, Andrade RA, Vianna LR, Reis AB, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Mallo MN, Martins-Filho OA: Despite Leisvaccine and Leismune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. Vaccine. 2008, 26: 2211-24. 10.1016/j.vaccine.2008.02.044.CrossRefPubMed Araujo MSS, Andrade RA, Vianna LR, Reis AB, Sathler-Avelar R, Teixeira-Carvalho A, Andrade MC, Mallo MN, Martins-Filho OA: Despite Leisvaccine and Leismune trigger distinct immune profiles, their ability to activate phagocytes and CD8+ T-cells support their high-quality immunogenic potential against canine visceral leishmaniasis. Vaccine. 2008, 26: 2211-24. 10.1016/j.vaccine.2008.02.044.CrossRefPubMed
34.
go back to reference Sheu BC, Kuo WH, Chen RJ, Huang KJ, Chow SN: Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. The Breast. 2008, 17: 604-610. 10.1016/j.breast.2008.06.001.CrossRefPubMed Sheu BC, Kuo WH, Chen RJ, Huang KJ, Chow SN: Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer. The Breast. 2008, 17: 604-610. 10.1016/j.breast.2008.06.001.CrossRefPubMed
35.
go back to reference Macchetti AH, Marana HRC, Silva JS, Andrade JM, Ribeiro-Silva A, Bighetti S: Tumor-infiltration CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics. 2006, 61 (3): 203-208. 10.1590/S1807-59322006000300004.CrossRefPubMed Macchetti AH, Marana HRC, Silva JS, Andrade JM, Ribeiro-Silva A, Bighetti S: Tumor-infiltration CD4+ T lymphocytes in early breast cancer reflect lymph node involvement. Clinics. 2006, 61 (3): 203-208. 10.1590/S1807-59322006000300004.CrossRefPubMed
36.
go back to reference Leong PP, Mohammad R, Ibrahim N, Ithnin H, Abdullah M, Davis WC, Seow HF: Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Immunology Letters. 2006, 102: 229-236. 10.1016/j.imlet.2005.09.006.CrossRefPubMed Leong PP, Mohammad R, Ibrahim N, Ithnin H, Abdullah M, Davis WC, Seow HF: Phenotyping of lymphocytes expressing regulatory and effector markers in infiltrating ductal carcinoma of the breast. Immunology Letters. 2006, 102: 229-236. 10.1016/j.imlet.2005.09.006.CrossRefPubMed
37.
go back to reference Forman J: T cells, the MHC, and function. Immunology. 1984, 81: 203-219. 10.1111/j.1600-065X.1984.tb01111.x.CrossRef Forman J: T cells, the MHC, and function. Immunology. 1984, 81: 203-219. 10.1111/j.1600-065X.1984.tb01111.x.CrossRef
38.
go back to reference Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H: The central role of CD4+ T cells in the antitumor immune response. Journal Experimental Medicine. 1998, 188 (12): 2357-2368. 10.1084/jem.188.12.2357.CrossRef Hung K, Hayashi R, Lafond-Walker A, Lowenstein C, Pardoll D, Levitsky H: The central role of CD4+ T cells in the antitumor immune response. Journal Experimental Medicine. 1998, 188 (12): 2357-2368. 10.1084/jem.188.12.2357.CrossRef
39.
go back to reference Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T: B cells inhibit induction of T cell-dependent tumor immunity. Nature Medicine. 1998, 4 (5): 627-630. 10.1038/nm0598-627.CrossRefPubMed Qin Z, Richter G, Schuler T, Ibe S, Cao X, Blankenstein T: B cells inhibit induction of T cell-dependent tumor immunity. Nature Medicine. 1998, 4 (5): 627-630. 10.1038/nm0598-627.CrossRefPubMed
40.
go back to reference Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC: Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. American Cancer Society. 1999, 86 (8): 1537-1543. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC: Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. American Cancer Society. 1999, 86 (8): 1537-1543.
41.
go back to reference Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement, 1999. Archives Pathology & Laboratory Medicine. 2000, 124: 966-978- Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG, O'Malley F, Simpson JF, Connolly JL, Hayes DF, Edge SB, Lichter A, Schnitt SJ: Prognostic factors in breast cancer. College of American Pathologists Consensus Statement, 1999. Archives Pathology & Laboratory Medicine. 2000, 124: 966-978-
42.
go back to reference Philibert JC, Snyder PW, Glickman N, Glickman LT, Waters J: Influence of host factors on survival in dogs with malignant mammary gland tumors. Journal Veterinary Internal Medicine. 2003, 17: 102-106.CrossRef Philibert JC, Snyder PW, Glickman N, Glickman LT, Waters J: Influence of host factors on survival in dogs with malignant mammary gland tumors. Journal Veterinary Internal Medicine. 2003, 17: 102-106.CrossRef
43.
go back to reference Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Veterinary and Comparative Oncology. 2009, 1-6. 193 Ferreira E, Bertagnolli AC, Cavalcanti MF, Schmitt FC, Cassali GD: The relationship between tumour size and expression of prognostic markers in benign and malignant canine mammary tumours. Veterinary and Comparative Oncology. 2009, 1-6. 193
44.
go back to reference Withrow SJ, Mac Eween EG: Tumors of the mammary gland. Small Animal Clinical Oncology. Edited by: Withrow SJ, Mac Eween EG. 2001, W. B. Saunders Company, Philadelphia, 455-77. 3 Withrow SJ, Mac Eween EG: Tumors of the mammary gland. Small Animal Clinical Oncology. Edited by: Withrow SJ, Mac Eween EG. 2001, W. B. Saunders Company, Philadelphia, 455-77. 3
45.
go back to reference Martı'n De Las Mulas J, Milla' NY, Dios R: A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology. 2005, 42: 200-212. 10.1354/vp.42-2-200.CrossRefPubMed Martı'n De Las Mulas J, Milla' NY, Dios R: A prospective analysis of immunohistochemically determined estrogen receptor α and progesterone receptor expression and host and tumor factors as predictors of disease-free period in mammary tumors of the dog. Veterinary Pathology. 2005, 42: 200-212. 10.1354/vp.42-2-200.CrossRefPubMed
46.
go back to reference Denkert C, Loibl S, Noske A, Roller M, MüLler BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C, von Törne C, Weichert W, Engels K, Solbach C, Schrader I, Dietel M, von Minckwitz G: Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. Journal of Clinical Oncology. 2010, 28 (1): 105-113. 10.1200/JCO.2009.23.7370.CrossRefPubMed Denkert C, Loibl S, Noske A, Roller M, MüLler BM, Komor M, Budczies J, Darb-Esfahani S, Kronenwett R, Hanusch C, von Törne C, Weichert W, Engels K, Solbach C, Schrader I, Dietel M, von Minckwitz G: Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer. Journal of Clinical Oncology. 2010, 28 (1): 105-113. 10.1200/JCO.2009.23.7370.CrossRefPubMed
47.
go back to reference Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology. 1998, 11 (2): 155-168.PubMed Allred DC, Harvey JM, Berardo M, Clark GM: Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Modern Pathology. 1998, 11 (2): 155-168.PubMed
48.
go back to reference Hellmén E, Bergström R, Holmberg L, Spangberg I-B, Hansson K, Lindgren A: Prognostic factors in canine mammary tumor: A multivariate study of 202 consecutive cases. Veterinary Pathology. 1993, 30: 20-27. 10.1177/030098589303000103.CrossRefPubMed Hellmén E, Bergström R, Holmberg L, Spangberg I-B, Hansson K, Lindgren A: Prognostic factors in canine mammary tumor: A multivariate study of 202 consecutive cases. Veterinary Pathology. 1993, 30: 20-27. 10.1177/030098589303000103.CrossRefPubMed
Metadata
Title
Immunophenotypic features of tumor infiltrating lymphocytes from mammary carcinomas in female dogs associated with prognostic factors and survival rates
Authors
Alessandra Estrela-Lima
Márcio SS Araújo
João M Costa-Neto
Andréa Teixeira-Carvalho
Stella M Barrouin-Melo
Sergio V Cardoso
Olindo A Martins-Filho
Rogéria Serakides
Geovanni D Cassali
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-256

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine